Literature DB >> 10936783

Moc-31, fibronectin and CEA in the differential diagnosis of malignant effusions: an immunocytochemical study.

P Athanassiadou1, M Gonidi, A Liossi, E Petrakakou, L Nakopoulou, C Zerva, P Athanassiades.   

Abstract

In discriminating benign and malignant origins of cytologically suspicious effusion smears a panel of antibodies against carcinoembryonic antigen (CEA), Fibronectin (F) and MOC-31 was used with immuno-cytochemical techniques. One hundred and thirty seven effusions were studied of which 107 had a malignant and 30 a benign aetiology as determined by clinical and histological examination. Cytologically 24 were diagnosed as benign, 97 as malignant and 14 as suspicious. Staining for F was positive in all effusions of benign and 3 of malignant origin. MOC-31 was positive in 95 (88.8%) of effusions of malignant origin but none of benign origin. Positive CEA was observed in 43% of effusions of malignant origin and in 10 of benign origin. The combination of MOC-31 positivity measured the sensitivity and specificity of the cytological examination in cases where the cytological examination result was suspicious as did F positivity improve the sensitivity for a benign origin of the effusion. Positivity or negativity for CEA is less valuable than the other parameters.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10936783     DOI: 10.1007/bf03032357

Source DB:  PubMed          Journal:  Pathol Oncol Res        ISSN: 1219-4956            Impact factor:   3.201


  11 in total

1.  Antigens of lung cancer: results of the second international workshop on lung cancer antigens.

Authors:  R L Souhami; P C Beverley; L G Bobrow; J A Ledermann
Journal:  J Natl Cancer Inst       Date:  1991-05-01       Impact factor: 13.506

2.  Immunohistochemical panel for distinguishing between carcinoma and reactive mesothelial cells in serious effusions.

Authors:  J S Lee; J H Nam; M C Lee; C S Park; S W Juhng
Journal:  Acta Cytol       Date:  1996 Jul-Aug       Impact factor: 2.319

3.  Use of avidin-biotin-peroxidase complex (ABC) in immunoperoxidase techniques: a comparison between ABC and unlabeled antibody (PAP) procedures.

Authors:  S M Hsu; L Raine; H Fanger
Journal:  J Histochem Cytochem       Date:  1981-04       Impact factor: 2.479

4.  Immunocytology of body cavity fluids. MOC-31, a monoclonal antibody discriminating between mesothelial and epithelial cells.

Authors:  T Ruitenbeek; A S Gouw; S Poppema
Journal:  Arch Pathol Lab Med       Date:  1994-03       Impact factor: 5.534

5.  Monoclonal antibodies in the cytodiagnosis of serous effusions.

Authors:  A al-Nafussi; P J Carder
Journal:  Cytopathology       Date:  1990       Impact factor: 2.073

6.  Immunohistochemical evaluation of seven monoclonal antibodies for differentiation of pleural mesothelioma from lung adenocarcinoma.

Authors:  P R Wirth; J Legier; G L Wright
Journal:  Cancer       Date:  1991-02-01       Impact factor: 6.860

7.  Identification of carcinoma cells in ascitic and pleural fluid. Comparison of four panepithelial antigens with carcinoembryonic antigen.

Authors:  J Mezger; O Stötzer; G Schilli; S Bauer; W Wilmanns
Journal:  Acta Cytol       Date:  1992 Jan-Feb       Impact factor: 2.319

8.  The cytologic application of carcinoembryonic antigen for the discrimination of malignant from benign serous effusions.

Authors:  K A Kyrkou; S G Iatridis; P P Athanassiadou; P P Athanassiadis; C E Mandragos
Journal:  Cancer Detect Prev       Date:  1985

9.  Immunoperoxidase demonstration of carcinoembryonic antigen in pleural and peritoneal effusions.

Authors:  M Sehested; E Ralfkjaer; J Rasmussen
Journal:  Acta Cytol       Date:  1983 Mar-Apr       Impact factor: 2.319

10.  Detection of benign or malignant origin of ascites with combined indirect immunoperoxidase assays of carcinoembryonic antigen and lysozyme.

Authors:  K A Kyrkou; S G Iatridis; P P Athanassiadou; A G Emmanouilidou; P P Athanassiadis
Journal:  Acta Cytol       Date:  1985 Jan-Feb       Impact factor: 2.319

View more
  2 in total

1.  Diagnostic accuracy of MOC-31 for malignant effusions: a meta-analysis.

Authors:  Diandian Li; Bo Wang; Qianjing Hu; Yongchun Shen; Dan Xu; Tao Wang; Fuqiang Wen
Journal:  Tumour Biol       Date:  2014-03-08

2.  Diagnostic value of E-cadherin and fibronectin in differentiation between reactive mesothelial and adenocarcinoma cells in serous effusions.

Authors:  Noushin Afshar Moghaddam; Reza Tahririan; Mehdi Eftekhari; Dana Tahririan; Alireza Rahmani
Journal:  Adv Biomed Res       Date:  2012-08-28
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.